Skip to main content

CambridgeSoft to Develop, Market Molecular Connections' NetPro Database

NEW YORK (GenomeWeb News) — CambridgeSoft will develop, market, and sell Indian informatics company Molecular Connections’ NetPro database, the companies said today.
NetPro contains information on small-molecule interactions collected from literature that is relevant to drug interactions, metabolism, enzyme kinetics, and potential therapeutic agents.
Under the agreement, Cambridge, Mass.-based CambridgeSoft will use its ChemOffice technology to develop a version of NetPro that is searchable by chemical structure.
Bangalore, India-based Molecular Connections' NetPro includes small molecules in a number of categories, including metabolites, physiologically available bioactive molecules, ligands, enzyme activators and inhibitors, agonists and antagonists, and bio-hazardous molecules such as allergens, carcinogens, and toxicants.
The companies said the integrated product will allow chemists to find information on nearly 86,000 small-molecule interactions.
Financial terms of the agreement were not released.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.